ArticleScientific reports2022

A transcriptomic signature for prostate cancer relapse prediction identified from the differentially expressed genes between TP53 mutant and wild-type tumors.

Wensheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.